Start your CPhI Experience with Pre-Connect - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Start your CPhI Experience with Pre-Connect


Although CPhI, ICSE, InnoPak and and P-Mec won’t begin until 9 October, you can start your CPhI experience a day earlier on 8 October by attending the preshow Pre-Connect Conference. The event will provide attendees with the opportunity to discuss the latest strategies in pharmaceutical development, manufacturing and partnering.

Different modules will be available throughout the conference, including generics and super generics; drug delivery systems, biosimilars and biobetters; API sourcing in emerging markets; strategic partnerships; and biomanufacturing.

Several speakers have already been confirmed, including Amer Alghabban, Director, Global Quality Assurance Auditing at Merck Serono, Danchen Gao, Director Intellectual Property Strategy at Abbott Laboratories, and Fidelma Callanan, Senior Director at Alkermes Contract Pharma Services.

The conference will be taking place at Feria de Madrid, the same location as CPhI.

You can find out more about the Pre-Connect Conference, including registration details, here.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here